Abstract
After the pandemic of SARS-CoV-2 infection, the development of the disease continues. The greatest challenge
today is the management of short- and long-term complications of COVID-19. The article provides a review of the latest data
from the world medical literature on current ideas about a wide range of neuropsychiatric consequences of COVID-19 with the
aim of studying their course and prevention in more depth.
References
Mazza MG, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594-600.
Agyeman AA, Chin KL, Landersdorfer CB, et al. Smell and taste dysfunction in COVID-19 patients: A systematic review and meta-analysis. Mayo Clin Proc. 2020;95(8):1621-1631.
Watson CJ, Thomas RH, Solomon T, et al. COVID-19 and psychosis: A review of 42 cases. Brain Behav Immun Health. 2021;14:100243.
Ferrando SJ, Klepacz L, Lynch S, et al. Psychiatric emergencies during the COVID-19 pandemic: Clinical characteristics and outcomes. J Psychiatr Res. 2020;129:60-66.
Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuroinflammation, psychiatric disorders and long COVID. Brain Behav Immun. 2020;87:34-39.
Wu, Yeshun et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity. 2020;87:18-22. doi:10.1016/j.bbi.2020.03.031
Steardo, Luca Jr et al. Psychiatric face of COVID-19. Translational psychiatry. 2020;10(1):261. doi:10.1038/s41398-020-00949-5
Gowrisankar, Yugandhar V, and Michelle A Clark. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. Journal of neurochemistry. 2016;138(1):74-85. doi:10.1111/jnc.13641
Shang, Jian et al. Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(21):11727-11734. doi:10.1073/pnas.2003138117
Fotuhi, Majid et al. Neurobiology of COVID-19. Journal of Alzheimer’s disease. JAD. 2020;76(1):3-19. doi:10.3233/JAD-200581